ArticleACS nano2026
Polymer Molecular Weight Influences Cancer Cell Surface Retention and Cytokine Presentation by Layer-by-Layer Nanoparticles.
Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Engineering the surface chemistry of nanoparticles (NPs) via the electrostatic layer-by-layer (LbL) assembly approach is a viable strategy for developing targeted drug delivery vehicles. However, how assembly solution conditions and polymer molecular weight (MW) govern LbL-NP properties remains poorly understood. We investigated the influence of layering buffer ionic strength and polymer MW on the functional performance of PLR/PLE bilayer-coated LbL-NPs designed to promote cancer cell targeting and NP retention on the extracellular membrane to deliver the cytokine interleukin-12 (IL-12). Assembly under mild ionic strength conditions increased LbL film stability but reduced IL-12 bioavailability and lipid exchange at the NP surface, ultimately diminishing therapeutic efficacy. In contrast, highly stable LbL-NPs assembled using high-MW (HMW) polymers under low ionic strength conditions exhibited enhanced in vitro NP association, increased cancer cell surface retention, and improved tumor accumulation in vivo in a metastatic ovarian cancer model, leading to improved efficacy and long-term survival. Molecular dynamics (MD) simulations revealed that HMW polymer layering produced denser PLE outer layer architecture compared to more highly interpenetrated LMW layers, providing structural insight into the superior performance of HMW LbL-NPs. These results demonstrate that control over LbL-NP delivery performance is influenced by polymer MW and assembly conditions, with HMW polymers augmenting the performance of PLR/PLE-coated NPs for IL-12 delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.